Novartis shares climb on strong Cosentyx sales, franchise growth, and a new malaria drug approval despite political risks.

During a live event, Jahan Aghalar, MD, discussed key NCCN-recommended oral therapies and landmark trials for metastatic ...

New research in the July 2025 issue of JNCCN-Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate cancer later in life, and treated ...

A local cancer survivor, Robert Dames, has released a new book titled "Cancer - What Now" to assist others in navigating the ...

ArteraAI Prostate analyzes digital pathology images of a prostate cancer biopsy slide to help clinicians predict long-term outcomes.

Real-world data suggest that Erleada may offer an advantage over other treatment options for patients with metastatic ...

Data from clinical trials have indicated that PSA is prognostic for outcomes, but little is known about real-world trends.

Nuclidium has raised 79 million Swiss francs ($99 million) as the Swiss and German biotech looks to continue the clinical ...

Design Cross-sectional postal survey of cancer survivors using a population-based sampling approach. Setting English National Health Service. Participants 4992 breast, colorectal, prostate and ...

The National Cancer Institute faces severe budget cuts, staff exodus, and halted research, threatening decades of progress ...

Researchers investigated how Mindfulness-Based Cancer Recovery and Tai Chi/Qijong interventions could reduce distress levels in cancer survivors.

Prostate and colorectal cancers are two of the most common cancers affecting men in the U.S., and Black men face ...